169 related articles for article (PubMed ID: 26309645)
1. Platelet abnormalities in chronic thromboembolic pulmonary hypertension.
Remková A; Šimková I; Valkovičová T
Int J Clin Exp Med; 2015; 8(6):9700-7. PubMed ID: 26309645
[TBL] [Abstract][Full Text] [Related]
2. Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
Bohacekova M; Kaldararova M; Valkovicova T; Remkova A; Vesely J; Simkova I
Bratisl Lek Listy; 2016; 117(10):577-582. PubMed ID: 27826972
[TBL] [Abstract][Full Text] [Related]
3. Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension.
Vrigkou E; Tsantes A; Konstantonis D; Rapti E; Maratou E; Pappas A; Halvatsiotis P; Tsangaris I
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626393
[TBL] [Abstract][Full Text] [Related]
4. Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome).
Remková A; Šimková I; Valkovičová T; Kaldarárová M
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):925-929. PubMed ID: 26829363
[TBL] [Abstract][Full Text] [Related]
5. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
7. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
Olman MA; Marsh JJ; Lang IM; Moser KM; Binder BR; Schleef RR
Circulation; 1992 Oct; 86(4):1241-8. PubMed ID: 1394930
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for chronic thromboembolic pulmonary hypertension.
Lang I; Kerr K
Proc Am Thorac Soc; 2006 Sep; 3(7):568-70. PubMed ID: 16963535
[TBL] [Abstract][Full Text] [Related]
9. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Wong CL; Szydlo R; Gibbs S; Laffan M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
[TBL] [Abstract][Full Text] [Related]
10. Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study.
Demirtunc R; Duman D; Basar M
Clin Drug Investig; 2007; 27(6):435-41. PubMed ID: 17506593
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors in chronic thromboembolic pulmonary hypertension].
Jiménez D; Gaudó J; Sueiro A
Arch Bronconeumol; 2009 Jun; 45 Suppl 6():11-4. PubMed ID: 20542195
[TBL] [Abstract][Full Text] [Related]
12. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N
Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension.
Bonderman D; Turecek PL; Jakowitsch J; Weltermann A; Adlbrecht C; Schneider B; Kneussl M; Rubin LJ; Kyrle PA; Klepetko W; Maurer G; Lang IM
Thromb Haemost; 2003 Sep; 90(3):372-6. PubMed ID: 12958604
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of tissue factor and its inhibitor in chronic thromboembolic pulmonary hypertension: a step closer to explanation of the disease aetiology?
Cisowska-Czajka ME; Mazij MP; Kotschy MH; Lewczuk J
Kardiol Pol; 2016; 74(11):1332-1338. PubMed ID: 27221958
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
[TBL] [Abstract][Full Text] [Related]
17. Molecular Research in Chronic Thromboembolic Pulmonary Hypertension.
Opitz I; Kirschner MB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759794
[TBL] [Abstract][Full Text] [Related]
18. The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension.
Yang M; Deng C; Wu D; Zhong Z; Lv X; Huang Z; Lian N; Liu K; Zhang Q
J Thromb Thrombolysis; 2016 Jul; 42(1):38-45. PubMed ID: 26667361
[TBL] [Abstract][Full Text] [Related]
19. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
Mühl D
Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
